Antidepressant Use in Pregnant and Postpartum Women
- 28 March 2014
- journal article
- review article
- Published by Annual Reviews in Annual Review of Clinical Psychology
- Vol. 10 (1) , 369-392
Abstract
Women in their reproductive years are at risk of experiencing depressive and anxiety disorders. As such, it is likely that pregnant women will undergo treatment with antidepressants. We review the risk of adverse birth outcomes and neonatal complications subsequent to antidepressant use in pregnancy. An inconsistent literature shows that antidepressant exposure is associated with shortened gestations and diminished fetal growth; these effects are small. Transitory neonatal signs are seen in some neonates after exposure to antidepressants in utero. No specific pattern of malformations has been consistently associated with antidepressants, with the possible exception of paroxetine and cardiac malformations. There is inconclusive evidence of a link between antidepressants in late pregnancy and persistent pulmonary hypertension in the newborn. Extensive study finds that antidepressants cannot be considered major teratogens. It is likely that confounding factors contribute to a number of the adverse effects found to be associated with antidepressant use in pregnancy.Keywords
This publication has 115 references indexed in Scilit:
- Increasing the risk of spontaneous abortion and major malformations in newborns following use of serotonin reuptake inhibitors during pregnancy: A systematic review and updated meta-analysisDARU Journal of Pharmaceutical Sciences, 2012
- Exposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: a nationwide cohort studyBMJ Open, 2012
- Does Antidepressant Use Attenuate the Risk of a Major Depressive Episode in Pregnancy?Epidemiology, 2011
- Use of antidepressants during pregnancy and the risk of spontaneous abortionCanadian Medical Association Journal, 2010
- Antidepressant Use During Pregnancy and the Risk of Preterm Delivery and Fetal Growth RestrictionJournal of Clinical Psychopharmacology, 2009
- Risk of preterm delivery and other adverse perinatal outcomes in relation to maternal use of psychotropic medications during pregnancyAmerican Journal of Obstetrics and Gynecology, 2009
- The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and GynecologistsGeneral Hospital Psychiatry, 2009
- Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational studyBritish Journal of Clinical Pharmacology, 2008
- Antipsychotic Therapy During Early and Late Pregnancy. A Systematic ReviewSchizophrenia Bulletin, 2008
- Psychiatric Disorders in Pregnant and Postpartum Women in the United StatesArchives of General Psychiatry, 2008